FPO. Storing Pradaxa (dabigatran etexilate).

Size: px
Start display at page:

Download "FPO. Storing Pradaxa (dabigatran etexilate)."

Transcription

1 B:16.5 T:16 S:15.5 a registered trademark of Boehringer Ingelheim Pharma GmbH & Co. KG and used under license. USECALL and THE NEW HOUSECALL with associated design are trademarks of Boehringer Ingelheim Pharmaceuticals, Inc. ands listed are trademarks of their respective owners, and are not trademarks of Boehringer Ingelheim Pharmaceuticals, Inc. f these brands are not affiliated with and do not endorse Boehringer Ingelheim Pharmaceuticals, Inc., or its products Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved. (3/12) Printed in the U.S.A PX182502CONS FPO 14 FS:4.625 F:5 FS:5.25 FS:5.125 F:5.5 F: FIFTH AVENUE NEW YORK, NY LEGAL RELEASE STATUS AD APPROVAL B:8.75 S:8 T:8.5 Storing Pradaxa (dabigatran etexilate).

2 Does my atrial fibrillation put me at greater risk for a stroke? Yes. Having atrial fi brillation, or AFib, puts you at 5 times greater risk of stroke.

3 Why Pradaxa (dabigatran etexilate)? In a clinical trial of over 18,000 non-valvular AFib patients... PRADAXA reduced stroke risk better than warfarin. 35% Risk reduction was greatest compared to warfarin patients whose blood tests showed lower levels of control. SELECT SAFETY INFORMATION 2

4 How is Pradaxa (dabigatran etexilate) different from warfarin? Risk reduction was greatest compared to warfarin patients whose blood tests showed lower levels of control. warfarin PRADAXA i warfarin comes in 1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg, 6mg, 7.5mg, and 10mg strengths. ii Pradaxa comes in 150mg and 75mg strengths. 3

5 SELECT SAFETY INFORMATION 4

6 How does Pradaxa (dabigatran etexilate) work? PRADAXA is a type of blood-thinning medication known as a direct thrombin inhibitor. found in your blood, ots to form. works by attaching itself to thrombin, the ability of a clot to form. 5

7 SELECT SAFETY INFORMATION 6

8 IMPORTANT SAFETY INFORMATION ABOUT PRADAXA See full Prescribing Information, including Medication Guide, in back pocket. 7

9 8

10 Can I save money on my prescription? The PRADAXA Savings Card provides valuable savings on your PRADAXA prescription. 9

11 Activate your enclosed savings card today and you may be eligible for one of the following based on your insurance status: -OR- Call to activate the enclosed savings card. You will automatically be enrolled in The New Housecall support program. Look for your card on the back cover. 10

12 Does Pradaxa (dabigatran etexilate) have a support program? Yes, The New Housecall support program is always there for you. 11

13 12

14 What should I know before I start taking Pradaxa (dabigatran etexilate)? Taking PRADAXA.

15 B:16.5 T:16 S:15.5 a registered trademark of Boehringer Ingelheim Pharma GmbH & Co. KG and used under license. USECALL and THE NEW HOUSECALL with associated design are trademarks of Boehringer Ingelheim Pharmaceuticals, Inc. ands listed are trademarks of their respective owners, and are not trademarks of Boehringer Ingelheim Pharmaceuticals, Inc. f these brands are not affiliated with and do not endorse Boehringer Ingelheim Pharmaceuticals, Inc., or its products Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved. (3/12) Printed in the U.S.A PX182502CONS FPO 14 FS:4.625 F:5 FS:5.25 FS:5.125 F:5.5 F: FIFTH AVENUE NEW YORK, NY LEGAL RELEASE STATUS AD APPROVAL B:8.75 S:8 T:8.5 Storing Pradaxa (dabigatran etexilate).

16 B:16.5 T:16 S:15.5 a registered trademark of Boehringer Ingelheim Pharma GmbH & Co. KG and used under license. USECALL and THE NEW HOUSECALL with associated design are trademarks of Boehringer Ingelheim Pharmaceuticals, Inc. ands listed are trademarks of their respective owners, and are not trademarks of Boehringer Ingelheim Pharmaceuticals, Inc. f these brands are not affiliated with and do not endorse Boehringer Ingelheim Pharmaceuticals, Inc., or its products Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved. (3/12) Printed in the U.S.A PX182502CONS FPO 14 FS:4.625 F:5 FS:5.25 FS:5.125 F:5.5 F: FIFTH AVENUE NEW YORK, NY LEGAL RELEASE STATUS AD APPROVAL B:8.75 S:8 T:8.5 Storing Pradaxa (dabigatran etexilate).

US FDA Approves Pradaxa (dabigatran etexilate) a breakthrough treatment for stroke risk reduction in non-valvular atrial fibrillation

US FDA Approves Pradaxa (dabigatran etexilate) a breakthrough treatment for stroke risk reduction in non-valvular atrial fibrillation Press Release For non-us Healthcare Media Boehringer Ingelheim GmbH Corporate Communications US FDA Approves Pradaxa (dabigatran etexilate) a breakthrough treatment for stroke risk reduction in non-valvular

More information

GLORIA -AF REGISTRY PROGRAMME

GLORIA -AF REGISTRY PROGRAMME GLORIA -AF REGISTRY PROGRAMME EXECUTIVE SUMMARY The approval of novel oral anticoagulants has changed prescribing patterns for stroke prevention in atrial fibrillation (AF) worldwide. 1 There is a need

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Oral Anticoagulants Page 1 of 7 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Oral Anticoagulant - Bevyxxa (betrixaban), Eliquis (apixaban), Pradaxa (dabigatran),

More information

MEDICATION GUIDE PRADAXA (pra dax a) (dabigatran etexilate mesylate) capsules

MEDICATION GUIDE PRADAXA (pra dax a) (dabigatran etexilate mesylate) capsules MEDICATION GUIDE PRADAXA (pra dax a) (dabigatran etexilate mesylate) capsules Read this Medication Guide before you start taking PRADAXA and each time you get a refill. There may be new information. This

More information

Clinical Policy: Dabigatran (Pradaxa) Reference Number: CP.PMN.49 Effective Date: Last Review Date: 05.18

Clinical Policy: Dabigatran (Pradaxa) Reference Number: CP.PMN.49 Effective Date: Last Review Date: 05.18 Clinical Policy: (Pradaxa) Reference Number: CP.PMN.49 Effective Date: 05.01.12 Last Review Date: 05.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

A Clinical Context Report

A Clinical Context Report Stroke Prevention in Atrial Fibrillation An Expert Commentary With Kenneth W. Mahaffey, MD A Clinical Context Report Stroke Prevention in Atrial Fibrillation Expert Commentary Jointly Sponsored by: and

More information

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate Service Notification in response to DHSSPS endorsed NICE Technology Appraisals NICE TA 249: Atrial fibrillation - Dabigatran Etexilate 1 Name of Commissioning Team Long Term Conditions Commissioning Team

More information

Diagnosed with AFib? Your journey with XARELTO starts here.

Diagnosed with AFib? Your journey with XARELTO starts here. THERE S MORE TO KNOW Diagnosed with AFib? Your journey with XARELTO starts here. Do not stop taking XARELTO without talking to your doctor. Stopping XARELTO increases your risk of having a stroke. 2 Welcome

More information

GENERAL PRACTITIONER v BOEHRINGER INGELHEIM

GENERAL PRACTITIONER v BOEHRINGER INGELHEIM CASE AUTH/2404/5/11 GENERAL PRACTITIONER v BOEHRINGER INGELHEIM Promotion of Pradaxa A general practitioner complained that a number of articles about Boehringer Ingelheim s product Pradaxa (dabigatran)

More information

Results from RE-LY and RELY-ABLE

Results from RE-LY and RELY-ABLE Results from RE-LY and RELY-ABLE Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in longterm stroke prevention EXECUTIVE SUMMARY Dabigatran etexilate (Pradaxa ) has shown a consistent

More information

CLINICAL AUDIT. Renal Function Testing in People. Taking Dabigatran

CLINICAL AUDIT. Renal Function Testing in People. Taking Dabigatran CLINICAL AUDIT Renal Function Testing in People Taking Dabigatran Valid to December 2017 bpac nz better medicin e Background Dabigatran is an oral anticoagulant used primarily to prevent stroke in people

More information

Alison Tennant MRPharmS MPH Head of Service Improvement and Quality Dudley CCG

Alison Tennant MRPharmS MPH Head of Service Improvement and Quality Dudley CCG Alison Tennant MRPharmS MPH Head of Service Improvement and Quality Dudley CCG Commissioning is the set of linked activities required to assess the healthcare needs of a population, specify the services

More information

A DECISION AID FOR AFIB STROKE PREVENTION FOR PATIENTS WITH ATRIAL FIBRILLATION

A DECISION AID FOR AFIB STROKE PREVENTION FOR PATIENTS WITH ATRIAL FIBRILLATION A DECISION AID FOR AFIB STROKE PREVENTION FOR PATIENTS WITH ATRIAL FIBRILLATION For Patients with VERY HIGH RISK You have atrial fibrillation, also known as AFib, which means you have an irregular heart

More information

Results from RE-COVER RE-COVER II RE-MEDY RE-SONATE EXECUTIVE SUMMARY

Results from RE-COVER RE-COVER II RE-MEDY RE-SONATE EXECUTIVE SUMMARY Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE Results from

More information

Medicines for stroke prevention in atrial fibrillation. Choosing the right one for you

Medicines for stroke prevention in atrial fibrillation. Choosing the right one for you Medicines for stroke prevention in atrial fibrillation Choosing the right one for you Atrial fibrillation (AF) is a condition that affects the heart, causing it to beat irregularly and too fast. When this

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE July 5, 2016 SUBJECT EFFECTIVE DATE July 11, 2016 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Anticoagulants - Pharmacy Services Leesa M. Allen, Deputy Secretary

More information

Pradaxa. [dabigatran etexilate] patient support booklet

Pradaxa. [dabigatran etexilate] patient support booklet Pradaxa [dabigatran etexilate] patient support booklet Important information about your medication and how to take it to help you reduce your risk of stroke associated with atrial fibrillation You have

More information

DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS?

DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS? To significantly reduce stroke risk from AFib and to treat and help prevent DVT and PE blood clots DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS? GET TO KNOW HOW THIS LATEST-GENERATION BLOOD THINNER HELPS PROTECT

More information

Oral Anticoagulants Update. Elizabeth Renner, PharmD, BCPS, BCACP, CACP Outpatient Cardiology and Anticoagulation

Oral Anticoagulants Update. Elizabeth Renner, PharmD, BCPS, BCACP, CACP Outpatient Cardiology and Anticoagulation Oral Anticoagulants Update Elizabeth Renner, PharmD, BCPS, BCACP, CACP Outpatient Cardiology and Anticoagulation Objectives List the direct oral anticoagulant (DOAC) drugs currently available Describe

More information

Diagnosed with DVT/PE blood clots? Your journey with XARELTO starts here.

Diagnosed with DVT/PE blood clots? Your journey with XARELTO starts here. THERE S MORE TO KNOW Diagnosed with DVT/PE blood clots? Your journey with XARELTO starts here. Do not stop taking XARELTO without talking to your doctor. Stopping XARELTO increases your risk of having

More information

Boehringer Ingelheim Page 6 of 178 Study report for non-interventional studies based on existing data BI Study Number

Boehringer Ingelheim Page 6 of 178 Study report for non-interventional studies based on existing data BI Study Number Page 6 of 178 report for non-interventional studies based on existing data BI Number 1160.144 c14462719-01 International GmbH or one or more of its affiliated companies 1. ABSTRACT Title of study: Keywords:

More information

A DECISION AID FOR AFIB STROKE PREVENTION FOR PATIENTS WITH ATRIAL FIBRILLATION

A DECISION AID FOR AFIB STROKE PREVENTION FOR PATIENTS WITH ATRIAL FIBRILLATION A DECISION AID FOR AFIB STROKE PREVENTION FOR PATIENTS WITH ATRIAL FIBRILLATION For Patients with HIGH RISK You have atrial fibrillation, also known as AFib, which means you have an irregular heart beat.

More information

Incorporating KT Concepts within Clinical Trials

Incorporating KT Concepts within Clinical Trials Incorporating KT Concepts within Clinical Trials The RELY-ABLE Trial as an Example Stuart Connolly & Robby Nieuwlaat Background - Dabigatran RE-LY Atrial fibrillation (AF) patients at high risk for stroke

More information

Clinical issues which drug for which patient

Clinical issues which drug for which patient Anticoagulants - a matter of heart! Towards a bright future? Clinical issues which drug for which patient Sabine Eichinger Dept. of Medicine I Medical University of Vienna/Austria Conflicts of interest

More information

The INR: No Need Anymore? Daniel Blanchard, MD Professor of Medicine Director, Cardiology Fellowship Program UCSD Sulpizio Cardiovascular Center

The INR: No Need Anymore? Daniel Blanchard, MD Professor of Medicine Director, Cardiology Fellowship Program UCSD Sulpizio Cardiovascular Center The INR: No Need Anymore? Daniel Blanchard, MD Professor of Medicine Director, Cardiology Fellowship Program UCSD Sulpizio Cardiovascular Center What is the INR? Tissue Factor (Factor III) is added to

More information

Xarelto and plavix taken together.

Xarelto and plavix taken together. Toggle navigation Xarelto and plavix taken together. Integrilin (eptifibatide) helps to prevent platelets in your blood from sticking together and forming a blood clot. An unwanted blood clot can occur

More information

The introduction of dabigatran etexilate (Pradaxa )

The introduction of dabigatran etexilate (Pradaxa ) The introduction of dabigatran etexilate (Pradaxa ) Draft frequently asked questions ~ October 2011 Contents 1 Introduction 3 2 Frequently asked questions 4 What is dabigatran and what is it used for?

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Anticoagulants A. Prescriptions That Require Prior Authorization Prescriptions for Anticoagulants

More information

INR as a Biomarker: Anticoagulation in Atrial Fib, Heart Failure, and Cardiovascular Disease Daniel Blanchard, MD, FACC, FAHA

INR as a Biomarker: Anticoagulation in Atrial Fib, Heart Failure, and Cardiovascular Disease Daniel Blanchard, MD, FACC, FAHA INR as a Biomarker: Anticoagulation in Atrial Fib, Heart Failure, and Cardiovascular Disease Daniel Blanchard, MD, FACC, FAHA Professor of Medicine Director, Cardiology Fellowship Program Sulpizio Cardiovascular

More information

Oral Anticoagulation Drug Class Prior Authorization Protocol

Oral Anticoagulation Drug Class Prior Authorization Protocol Oral Anticoagulation Drug Class Prior Authorization Protocol Line of Business: Medicaid P & T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review

More information

SAVAYSA (edoxaban tosylate) oral tablet

SAVAYSA (edoxaban tosylate) oral tablet SAVAYSA (edoxaban tosylate) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

Change from lovenox to pradaxa

Change from lovenox to pradaxa P ford residence southampton, ny Change from lovenox to pradaxa 14-11-2017 We wanted to put out a friendly reminder that the Ask 3 Teach 3 (A3T3) initiative is indeed full swing. This is an multidisciplinary

More information

Title Patients receiving dabigatran requiring emergency reversal for surgery or treatment of haemorrhage Guidelines. Department.

Title Patients receiving dabigatran requiring emergency reversal for surgery or treatment of haemorrhage Guidelines. Department. Document Control Title Patients receiving dabigatran requiring emergency reversal for surgery or treatment of haemorrhage Guidelines Author Author s job title Pharmacist Directorate PCS - Department Version

More information

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16 pat hways Anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs) Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16 Options for local implementation NICE

More information

to a DOAC anticoagulants (DOACs) dosing of DOACs for various indications switching from a DOAC and switching

to a DOAC anticoagulants (DOACs) dosing of DOACs for various indications switching from a DOAC and switching Linda Kelly, PharmD, PhC, CACP Presbyterian Healthcare Services } Identify the FDA approved direct oral anticoagulants (DOACs) } Distinguish the differences in the dosing of DOACs for various indications

More information

Atrial Fibrillation Topics for Today. Clinical Controversies Management of Atrial Fibrillation. Atrial Fibrillation in the ER Topics for Today

Atrial Fibrillation Topics for Today. Clinical Controversies Management of Atrial Fibrillation. Atrial Fibrillation in the ER Topics for Today Clinical Controversies Management of Atrial Fibrillation Yerem Yeghiazarians, M.D. Associate Professor of Medicine Leone-Perkins Family Endowed Chair in Cardiology Atrial Fibrillation Topics for Today

More information

Drug Use Criteria: Direct Oral Anticoagulants

Drug Use Criteria: Direct Oral Anticoagulants Texas Vendor Drug Program Drug Use Criteria: Oral Anticoagulants Publication History 1. Developed March 2017. 2. Revised February 2018. Notes: Information on indications for use or diagnosis is assumed

More information

The INR: No Need Anymore? Daniel Blanchard, MD Professor of Medicine Director, Cardiology Fellowship Program UCSD Sulpizio Cardiovascular Center

The INR: No Need Anymore? Daniel Blanchard, MD Professor of Medicine Director, Cardiology Fellowship Program UCSD Sulpizio Cardiovascular Center The INR: No Need Anymore? Daniel Blanchard, MD Professor of Medicine Director, Cardiology Fellowship Program UCSD Sulpizio Cardiovascular Center What is the INR? Tissue Factor (Factor III) is added to

More information

Blood-thinning medication after stroke

Blood-thinning medication after stroke Call the Stroke Helpline: 0303 3033 100 or email: info@stroke.org.uk Blood-thinning medication after stroke Blood-thinning medicines are drugs that help to prevent clots forming in your blood. They are

More information

DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS?

DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS? To significantly reduce stroke risk from AFib and to treat and help prevent DVT and PE blood clots DO YOU HAVE AFIB OR DVT/PE BLOOD CLOTS? GET TO KNOW HOW THIS LATEST-GENERATION BLOOD THINNER HELPS PROTECT

More information

Use of Propensity Scores to Assess Comparability of Treatment Groups in a Registry Program

Use of Propensity Scores to Assess Comparability of Treatment Groups in a Registry Program Use of Propensity Scores to Assess Comparability of Treatment Groups in a Registry Program Kenneth J Rothman On behalf of Menno V Huisman, Gregory Y.H. Lip, Hans-Christoph Diener, Sergio J Dubner, Chang-Sheng

More information

Fact or Fiction? All Patients Will Use NOACS Instead of Warfarin in 10 Years:

Fact or Fiction? All Patients Will Use NOACS Instead of Warfarin in 10 Years: All Patients Will Use NOACS Instead of Warfarin in 10 Years: Fact or Fiction? Cash Casey, MD Advocate Medical Group/ Midwest Heart Specialists December 3 rd, 2016 Disclosures Advisory board/speakers bureau:

More information

Important News Regarding Helixate FS, Antihemophilic Factor (Recombinant):

Important News Regarding Helixate FS, Antihemophilic Factor (Recombinant): Important News Regarding Helixate FS, Antihemophilic Factor (Recombinant): Availability and what comes next Please see Important Safety Information on pages 10 11 and accompanying full prescribing information,

More information

Comparison of novel oral anticoagulants (NOACs)

Comparison of novel oral anticoagulants (NOACs) Comparison of novel oral anticoagulants (NOACs) For guidance for full information refer to individual SPCs available at www.medicines.org.uk Licensed indications for NOACs Prevention of stroke and systemic

More information

Management of haemorrhage in patients taking DOACs/ NOACs (direct/ novel oral anticoagulants) Guideline. Contents

Management of haemorrhage in patients taking DOACs/ NOACs (direct/ novel oral anticoagulants) Guideline. Contents Management of haemorrhage in patients taking DOACs/ NOACs (direct/ novel oral anticoagulants) Guideline Classification: Clinical Guideline Lead Author: Dr Rowena Thomas-Dewing, Consultant Haematologist

More information

Eliquis effect on inr prolongation 2017

Eliquis effect on inr prolongation 2017 Eliquis effect on inr prolongation 2017 The Borg System is 100 % Eliquis effect on inr prolongation 2017 Dec 17, 2016. Clin Chem Lab Med 2017; 55(8): e178 e180. Letter to the Editor. Tuukka A. Helin. prolongs

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation Consensus Statement ~ October 2011 Contents 1 About 3 2 Introduction 5 3 Development of the consensus

More information

Plavix eliquis and aspirin

Plavix eliquis and aspirin Plavix eliquis and aspirin The Borg System is 100 % Plavix eliquis and aspirin 273 medications are known to interact with Plavix. Includes amlodipine, aspirin, Aspirin Low Strength ( aspirin ). Eliquis

More information

Lovenox to xarelto The Borg System is 100 % Retrievable & Reusable Lovenox to xarelto

Lovenox to xarelto The Borg System is 100 % Retrievable & Reusable Lovenox to xarelto Lovenox to xarelto The Borg System is 100 % Lovenox to xarelto Background: I got a DVT in my left calf after my fifth knee surgery. I'm a 32yo healthy, competitive athlete and have never had any healthy

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised Name: generic (trade) Dabigatran etexilate (Pradaxa ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised Direct thrombin inhibitor

More information

Direct Oral Anticoagulants

Direct Oral Anticoagulants Direct Oral Anticoagulants Holly Jahn, PharmD, CACP Objectives Identify the FDA approved indications for use, appropriate dosing, and monitoring parameters for each direct oral anticoagulant. Distinguish

More information

Drug Class Monograph

Drug Class Monograph Drug Class Monograph Class: Oral Anticoagulants Drug: Coumadin (warfarin), Eliquis (apixaban), Pradaxa (dabigatran), Savaysa (edoxaban), arelto (rivaroxaban) Formulary Medications: Eliquis (apixaban),

More information

Edoxaban Switch Programme - Frequently Asked Questions

Edoxaban Switch Programme - Frequently Asked Questions Edoxaban Switch Programme - Frequently Asked Questions What should I tell patients? NHS Tayside is reviewing all patients currently receiving a Direct Oral Anticoagulant (DOAC) for stroke prevention in

More information

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation Patient Preference and Adherence open access to scientific and medical research Open Access Full Text Article Original Research Survey of the use of warfarin and the newer anticoagulant dabigatran in patients

More information

Reducing the Risk of Stroke Associated With Nonvalvular Atrial Fibrillation in the VHA

Reducing the Risk of Stroke Associated With Nonvalvular Atrial Fibrillation in the VHA DECEMBER 21 VOL. 27 SUPPL. 1 A SUPPLEMENT TO www.fedprac.com Reducing the Risk of Stroke Associated With Nonvalvular Atrial Fibrillation in the VHA Diagnosing and Treating Atrial Fibrillation in the VHA

More information

LIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS

LIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS LIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS Learn what your cholesterol levels actually mean, and how you may save money on your prescription each month with the LIPITOR

More information

PRICING EXAMPLES (PER AID): Starkey Z Series i20 ReSound LiNX 2 5. December 11, Dear CVT Member,

PRICING EXAMPLES (PER AID): Starkey Z Series i20 ReSound LiNX 2 5. December 11, Dear CVT Member, December 11, 2015 Dear CVT Member, California s Valued Trust (CVT) wants to make you aware of a valuable hearing aid program available to you. CVT is pleased to offer you a great way to save on hearing

More information

BIOTRONIK Clinical Studies IMPACT Clinical Study Patient Information. IMPACT Clinical Study: Patient Information Guide

BIOTRONIK Clinical Studies IMPACT Clinical Study Patient Information. IMPACT Clinical Study: Patient Information Guide BIOTRONIK Clinical Studies IMPACT Clinical Study Patient Information IMPACT Clinical Study: Patient Information Guide Introduction and Objectives IMPACT is a clinical research study. Approximately 2,700

More information

Preventing Stroke in Patients with Atrial Fibrillation: USING THE EVIDENCE

Preventing Stroke in Patients with Atrial Fibrillation: USING THE EVIDENCE Preventing Stroke in Patients with Atrial Fibrillation: USING THE EVIDENCE What Is Atrial Fibrillation? Atrial fibrillation also called AFib or AF is the most common abnormal heart rhythm, affecting an

More information

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: All patients

More information

Results from the ENSURE-AF study were presented during the ESC Congress 2016 Hot Line session and the full results are published in The Lancet

Results from the ENSURE-AF study were presented during the ESC Congress 2016 Hot Line session and the full results are published in The Lancet Press Release ENSURE-AF Data Support the Efficacy and Safety Profile of Daiichi Sankyo s Once-Daily LIXIANA in Patients with Atrial Fibrillation Undergoing Cardioversion ENSURE-AF is the largest clinical

More information

Idarucizumab for Dabigatran Reversal Pollack CV, Reilly PA, Eikelboom J, et al. N Engl J Med 2015; 373(6):

Idarucizumab for Dabigatran Reversal Pollack CV, Reilly PA, Eikelboom J, et al. N Engl J Med 2015; 373(6): Idarucizumab for Dabigatran Reversal Pollack CV, Reilly PA, Eikelboom J, et al. N Engl J Med 2015; 373(6):511-520. Objective: To measure the safety of idarucizumab to reverse dabigatran anticoagulant effects

More information

ESC Congress 2012, Munich

ESC Congress 2012, Munich ESC Congress 2012, Munich Anticoagulation in Atrial Fibrillation 2012: Which Anticoagulant for Which Patient? Stefan H. Hohnloser J.W. Goethe University Frankfurt am Main S.H.H. has served as a consultant,

More information

Technology appraisal guidance Published: 15 March 2012 nice.org.uk/guidance/ta249

Technology appraisal guidance Published: 15 March 2012 nice.org.uk/guidance/ta249 Dabigatran an etexilate for the preventionention of stroke and systemic embolism in atrial fibrillation Technology appraisal guidance Published: 15 March 2012 nice.org.uk/guidance/ta249 NICE 2012. All

More information

Your Prescription Card. Your guide for savings.

Your Prescription Card. Your guide for savings. 3 Paragon Drive Montvale, NJ 07645 >00001 00001 001 P50708 _PM 7873 GROUP JOHN Q SAMPLE 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 APDNCLDJDKDIFPAKHPANEMFK AJCLLKEBEKNJJBNMPKGOKIKK AMBPIBPEAKHEIOBKFGFBOMMK

More information

Drug Class Review Newer Oral Anticoagulant Drugs

Drug Class Review Newer Oral Anticoagulant Drugs Drug Class Review Newer Oral Anticoagulant Drugs Final Original Report May 2016 The purpose of reports is to make available information regarding the comparative clinical effectiveness and harms of different

More information

Finish the course for as little as $ Start the course for as little as

Finish the course for as little as $ Start the course for as little as HELP YOUR PATIENTS ACCESS IRON* INJECTAFER Restrictions apply. For Adult IDA Patients With Iron Deficits, Consider the Injectafer Savings Program* Start the course for as little as $ 50 FIRST DOSE up to

More information

Home Delivery Pharmacy Program. mycigna.com k 1/07

Home Delivery Pharmacy Program. mycigna.com k 1/07 Home Delivery Pharmacy Program mycigna.com 572507k 1/07 Stop Waiting in Line You need a reliable source for the prescription medications you and other covered family members take regularly. The CIGNA

More information

Take CYCLOSET exactly as instructed by your health care provider, and be sure to read the Patient Information section of the package insert.

Take CYCLOSET exactly as instructed by your health care provider, and be sure to read the Patient Information section of the package insert. To help adults control type 2 diabetes along with diet and exercise UNLOCK YOUR INSULIN POTENTIAL A once-daily treatment that works in the brain to help you become more responsive to the insulin in your

More information

TruHearing $1,250 $1,130

TruHearing $1,250 $1,130 December 1, 2014 Dear CVT Member, California s Valued Trust (CVT) wants to make you aware of a valuable hearing aid program available to you. CVT is pleased to offer you a great way to save on hearing

More information

CLINICAL AUDIT. Safe and Effective. Anticoagulation. with Warfarin

CLINICAL AUDIT. Safe and Effective. Anticoagulation. with Warfarin CLINICAL AUDIT Safe and Effective Anticoagulation with Warfarin Valid to September 2013 bpac nz better medicin e Focus of this audit This audit focuses on the safer prescribing of warfarin to help maintain

More information

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

The choice is clear.

The choice is clear. Trying to lower very high triglycerides? The choice is clear. Pure EPA Omega-3 Clinically proven FDA-approved Ask your doctor about VASCEPA, the first and only Pure EPA prescription Omega-3. Triglycerides

More information

Relief, true to form

Relief, true to form For adults with Chronic Idiopathic Constipation (CIC) or Irritable Bowel Syndrome with Constipation (IBS-C) Relief, true to form When It Comes to Constipation Relief, Form Matters Trulance can help you

More information

The effect of the direct oral anticoagulants (DOACs) on haemostasis tests.

The effect of the direct oral anticoagulants (DOACs) on haemostasis tests. The effect of the direct oral anticoagulants (DOACs) on haemostasis tests. Emmanuel J Favaloro, Haematology, ICPMR, Pathology West, Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital (with

More information

Appendix C Factors to consider when choosing between anticoagulant options and FAQs

Appendix C Factors to consider when choosing between anticoagulant options and FAQs Appendix C Factors to consider when choosing between anticoagulant options and FAQs Choice of anticoagulant for non-valvular* atrial fibrillation: Clinical decision aid Patients should already be screened

More information

WORTH A CLOSER LOOK.

WORTH A CLOSER LOOK. A birth control pill... WORTH A CLOSER LOOK. Ask your healthcare provider about. Please see Important Safety Information including Boxed Warning throughout this brochure and on pages 4 and 5. offers a

More information

Technician Training Tutorial: Dispensing Oral Blood Thinners

Technician Training Tutorial: Dispensing Oral Blood Thinners (Page 1 of 5) Technician Training Tutorial: Dispensing Oral Blood Thinners Warfarin (Coumadin, Jantoven-U.S., others) is an oral anticoagulant blood thinner used to help prevent blood clots that can lead

More information

Discussion guide. Questions to bring to your next doctor s appointment. Notes

Discussion guide. Questions to bring to your next doctor s appointment. Notes Discussion guide Questions to bring to your next doctor s appointment As someone who has had a heart attack or has peripheral arterial disease (PAD), it s important to lower your chance of having a heart

More information

Warfarin & You By V. B. Blake

Warfarin & You By V. B. Blake Warfarin & You By V. B. Blake Warfarin is an anticoagulant used to to prevent heart attacks, strokes, and blood clots. Learn about side effects, interactions and indications. Can you tell me what I should

More information

Interested parties (organisations or individuals) that commented on the draft document as released for consultation.

Interested parties (organisations or individuals) that commented on the draft document as released for consultation. 31 May 2018 EMA/CHMP/258276/2017 Committee for Medicinal Products for Human Use (CHMP) Overview of comments received on 'Dabigatran etexilate, hard capsules, 75 mg, 110 mg and 150 mg productspecific bioequivalence

More information

Get the Facts on Atrial Fibrillation

Get the Facts on Atrial Fibrillation Get the Facts on Atrial Fibrillation The content provided here is for informational purposes only. It is not intended to diagnose or treat a health problem or disease, or to replace professional medical

More information

FlexRx 6-Tier. SM Pharmacy Benefit Guide

FlexRx 6-Tier. SM Pharmacy Benefit Guide FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many

More information

Anticoagulation Beyond Coumadin

Anticoagulation Beyond Coumadin Anticoagulation Beyond Coumadin Saturday, September 21, 2013 Crystal Mountain Resort and Spa Pratik Bhattacharya MD, MPH Stroke Neurologist, Michigan Stroke Network; Assistant Professor of Neurology; Wayne

More information

The era of NOACs. (non-vitamin K oral anticoagulants) in Clinical Pharmacy : Patrick Tilleul

The era of NOACs. (non-vitamin K oral anticoagulants) in Clinical Pharmacy : Patrick Tilleul The era of NOACs (non-vitamin K oral anticoagulants) in Clinical Pharmacy : Patrick Tilleul Head Pharmacist, Pitié Salpêtrière hospital Associate professor Paris Sorbonne University Disclosure Patrick

More information

2017 FAQs. Dental Plan. Frequently Asked Questions from employees

2017 FAQs. Dental Plan. Frequently Asked Questions from employees 2017 FAQs Dental Plan Frequently Asked Questions from employees September 2016 Dental plan Questions we ve heard our employees ask Here are some commonly asked questions about the Dental plan that our

More information

Atrial Fibrillation and Options to Reduce Your Risk of Blood Clots and Stroke

Atrial Fibrillation and Options to Reduce Your Risk of Blood Clots and Stroke YOUR VALUES YOUR PREFERENCES YOUR CHOICE Atrial Fibrillation and Options to Reduce Your Risk of Blood Clots and Stroke Anticoagulant Medicine and Left Atrial Appendage Occlusion Device Understanding Your

More information

CARD 1: What is AFib and how does it relate to stroke? Talk to your patient about their condition and its connection to stroke.

CARD 1: What is AFib and how does it relate to stroke? Talk to your patient about their condition and its connection to stroke. 4WARD CONVERSATION CARDS OVERVIEW Please find educational materials to facilitate shared decision making between you and your atrial fibrillation (AFib) patients. More information can be found at AFib4WARD.com.

More information

National Institute for Health and Clinical Excellence Health Technology Appraisal

National Institute for Health and Clinical Excellence Health Technology Appraisal National Institute for Health and Clinical Excellence Health Technology Appraisal Rivaroxaban for the prevention of venous thromboembolism after elective orthopaedic surgery of the lower limbs Comment

More information

Disclosure. Financial disclosure: National Advisory Board & Research Grant from Boehringer-Ingelheim

Disclosure. Financial disclosure: National Advisory Board & Research Grant from Boehringer-Ingelheim Randomised Dabigatran Etexilate Dose Finding Study In Patients With Acute Coronary Syndromes Post Index Event With Additional Risk Factors For Cardiovascular Complications Also Receiving Aspirin and Clopidogrel

More information

Patient Information. For patients with diabetes, if you are taking TWYNSTA you should not take aliskiren.

Patient Information. For patients with diabetes, if you are taking TWYNSTA you should not take aliskiren. Patient Information TWYNSTA (TWIN-stah) (telmisartan/amlodipine) Tablets Read this Patient Information before you start taking TWYNSTA tablets and each time you get a refill. There may be new information.

More information

RECEIVING YOUR PERMANENT

RECEIVING YOUR PERMANENT 00001 JOHN Q SAMPLE 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 3118-00001_PM City of Savannah 132 E. Broughton Street Savannah, GA 31401 THIS IS A ONE-TIME CARD TO BE USED UNTIL YOUR PERMANENT CARD ARRIVES

More information

KCS Congress: Impact through collaboration

KCS Congress: Impact through collaboration Stroke Prevention in Atrial Fibrillation (SPAF) in Kenya Elijah N. Ogola FACC University of Nairobi Kenya Cardiac Society Annual Scientific Congress Mombasa 28 th June 1 st July 2017 KCS Congress: Impact

More information

Novel Anticoagulant Drugs. by: Dr. M. Kamandi Fellowship of hematology and Oncology

Novel Anticoagulant Drugs. by: Dr. M. Kamandi Fellowship of hematology and Oncology Novel Anticoagulant Drugs by: Dr. M. Kamandi Fellowship of hematology and Oncology A-Novel Oral Anticoagulants A drug that is: safe and effective has predictable pharmacology has few drug drug and drug

More information

On behalf of the RE-CIRCUIT Investigators. March 19, :45 am 10:55 am. Johns Hopkins Medical Institutions, Baltimore, MD, USA.

On behalf of the RE-CIRCUIT Investigators. March 19, :45 am 10:55 am. Johns Hopkins Medical Institutions, Baltimore, MD, USA. Safety and Efficacy of Uninterrupted Anticoagulation with Dabigatran Etexilate versus Warfarin in Patients Undergoing Catheter Ablation of Atrial Fibrillation: The RE-CIRCUIT Study Hugh Calkins, M.D.,

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY

More information

On behalf of the RE-CIRCUIT Investigators. March 19, :45 am 10:55 am. Johns Hopkins Medical Institutions, Baltimore, MD, USA.

On behalf of the RE-CIRCUIT Investigators. March 19, :45 am 10:55 am. Johns Hopkins Medical Institutions, Baltimore, MD, USA. Safety and Efficacy of Uninterrupted Anticoagulation with Dabigatran Etexilate versus in Patients Undergoing Catheter Ablation of Atrial Fibrillation: The RE-CIRCUIT Study Hugh Calkins, M.D., 1 Stephan

More information

Update with the New Oral Anticoagulants: Today s Issues for the Front Line Pharmacist

Update with the New Oral Anticoagulants: Today s Issues for the Front Line Pharmacist Update with the New Oral Anticoagulants: Today s Issues for the Front Line Pharmacist Peter Thomson, Pharm D. Clinical Resource Pharmacist, Medicine Program Winnipeg Regional Health Authority Clinical

More information